ArticleFrontiers in medicine2025
The impact of high BMI on the global burden of osteoarthritis from 1990 to 2021 and future projections.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Gait Biomechanics, Symmetry Restoration, and Functional Recovery Following Total Knee Arthroplasty: A Prospective Longitudinal Cohort Study.Life (Basel, Switzerland) · 2026Article
- Perceptions of Glucagon-like Peptide 1 Receptor Agonists Among Individuals With Knee Osteoarthritis and Excess Weight: A Qualitative Study.ACR open rheumatology · 2026Article
- Tracking global quality of life trajectories in knee osteoarthritis: a population-based long-term analysis.Therapeutic advances in musculoskeletal disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Osteoarthritis (OA) is a major global cause of disability, predominantly affecting weight-bearing joints such as the knee and hip. High body mass index (BMI) is a well-established modifiable risk factor for OA. This study aimed to estimate the global burden of OA attributable to high BMI from 1990 to 2021 and to project its trends through 2036 using the Global Burden of Disease (GBD) 2021 database. Methods: We analyzed OA-related years lived with disability (YLDs) attributable to high BMI, focusing on knee and hip OA. Regional and sociodemographic disparities were evaluated using the Socio-demographic Index (SDI). Future burden trends were projected using a Bayesian Age-Period-Cohort (BAPC) model. Frontier analysis was employed to assess potential gains in health system performance. Results: From 1990 to 2021, global OA YLDs attributable to high BMI increased substantially, driven by rising obesity rates, population aging, and demographic changes. Knee OA showed the greatest increase, especially in low- and middle-SDI regions, whereas hip OA burdens were more concentrated in high-SDI regions. The BAPC model projected continued increases in YLDs through 2036. Frontier analysis revealed substantial gaps between actual and optimal OA burdens, particularly in developing regions. Discussion: Our findings highlight the growing impact of high BMI on OA burden, with pronounced regional inequalities. There is an urgent need for targeted prevention strategies, improved OA management, and optimized resource allocation, especially in low-SDI and rapidly developing areas. These results support the development of precision public health strategies to mitigate the rising burden of BMI-related OA worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.